Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.
Meeting date | Uploaded by | Slides | Comments |
|---|---|---|---|
2 May 2012 | Julie | PFIM Interface 3.1 - cours M2R 10-11.pdf |
|
15 May 2012 | Angelina |
| |
6 June 2012 | Joe |
| |
13 June 2012 | Joanna | EMA geriatric workshop - March 2012 - Shepard (submitted 19March).ppt | Terry Shepard's Slides |
12 October 2012 | Rollo |
| |
9 November 2012 | Joanna |
| |
13 November 2012 | Julie |
| |
14 December 2012 | Lilia | Modelling neutrophil dynamics in children following bone marrow transplant |
|
22 Februrary 2013 | Allienor Berges |
| |
1 March 2013 | Rollo |
| |
28 May 2013 | Charlotte |
|
...
9 May 2012 | PUW1 | Joanna | Immunology |
16 May 2012 | WCJ | Angelina | Zidovudine PK/PG |
23 May 2012 | PUW2 | Jig | LMWH in pregnancy |
30 May 2012 | No meeting |
|
|
6 June 2012 | PUW1 | Joe | Antimicrobial PKPD |
13 June 2012 | PUW1 | Terry Shepard | Geriatric PKPD |
20 June 2012 | PUW2 | Rollo/Joanna | Immunology modelling |
27 June 2012 | No meeting |
|
|
4th July 2012 | No meeting |
|
|
11th July 2012 | PUW2 | Julie | PAGE review |
18th July 2012 | PUW2 | Katie | Gentamicin in burns |
12/10/12 1pm | WCA | Rollo | Modelling of the immune reconstitution post BMT |
19/10/12 1pm | PUW3 | Joe | Prague Biometrics 2012;68:902-11 |
26/10/12 1pm | PUW3 | Charlotte | NAPPA (Beta lactam pharmacokinetics/pharmacodynamics) plans |
2/11/12 1pm | PUW3 | Eva | Neogent (developing Bayesian therapeutic drug monitoring) progress |
9/11/12 1pm | PUW3 | Joanna | Inference methods course review |
16/11/12 1pm | PUW2 |
| General discussion |
23/11/12 1pm | PUW3 | Julie | Covariate selection methods in pharmacokinetic modelling |
30/11/12 1pm | PUW3 | Julie | NCA versus modelling in phase I studies for drugs with long half-life |
7/12/12 1pm | PUW3 |
| Goldacre talk |
14/12/12 1pm | PUW3 | Lilia | Neutropenia post-BMT |
...
1/9/14 | LGSR | Joe | Antimicrobial PKPD IDM_clinpharm_Standing_2014.pdf |
8/9/14 meeting starts 2pm | Levinski | Julie | DDMore language |
15/9/14 | LGSR | Paul | Pharmacogenetics of diclofenac |
22/9/14 | LGSR | Yucheng | Count data models and introduction to Pirana |
29/9/14 | LGSR | Andreas | Gabapentin PKPD in paediatric neuropathic pain |
6/10/14 | LGSR | Liana | Tyrosine kinase inhibitor effects in polycystic kindney disease |
13/10/14 | LGSR | Joanna |
|
20/10/14 | LGSR | Rollo | Short-term neutrophil and lymphocyte HSCT models |
27/10/14 | LGSR | Eva | NeoGent PKUK practice |
3/11/14 | LGSR | Seb | Item Response Theory: Application to NLME |
10/11/14 | LGSR | Joe | A new mechanistic model for antiretroviral pharmacodynamics |
17/11/14 | LGSR | Alberto | Anaesthesia depth with 3 different EEG measures |
24/11/14 | LGSR | Suzanne Reeves | Mechanisms underpinning antipsychotic sensitivity in Alzheimer's disease |
1/12/14 | LGSR | Deji | Mixed Effect Modelling in Hep C-HIV coinfected children |
8/12/14 meeting starts at 2pm | LGSR | TBC | To be confirmed |
15/12/14 | LGSR | Morris | Understanding the determinants of drug exposure and pharmacokinetic variability in tuberculosis patients |
Date | Location* | Presenter | Topic |
|---|---|---|---|
| 12/1/15 | PUW3 | Lynette Phee | Modelling antimicrobial synergy |
| 19/1/15 | PUW3 | Michael Betancourt | Bayesian approaches in NLMEM |
| 26/1/15 | PUW4 | Deji | pre-Upgrade Talk |
| 2/2/15 | PUW3 | Joe | Study design peer review/journal club |
| 9/2/15 | PUW3 | Eva | Comparing methods for paediatric PK scaling |
| 16/2/15 | PUW3 | Ajay Sinha | Amikacin and Vancomycin PK in neonates |
| 23/2/15 | PUW4 | Julie | Joint modeling of Tenofovir plasmatic and intracellular concentrations - The COPHAR3 trial |
| 2/3/15 | PUW3 | Karin Seifert | Establishing PK/PD relationships of anti-leishmanial drugs |
| 9/3/15 | PUW3 | Joe | Antimicrobial PKPD, refresher and future directions |
| 16/3/15 | PUW3 | Sophie | Vaccine dyamics with NLME |
| 23/3/15 | PUW4 | Suzanne | Amisulpride PKPD |
| 30/3/15 | PUW3 | Morris | Determinants of variability in drug exposure and implications for dose selection in tuberculosis patients |
| 13/4/15 | PUW2 | Andreas | Gabapentin for neuropathic pain |
| 20/4/15 | PUW3 | Joe | NLME tutorial |
| 27/4/15 | PUW4 | Yucheng | Propofol in ICU |
| 11/5/15 | PUW3 | Iblal | Benzylpenicillin neonatal PK |
| 18/5/15 | PUW3 | Joe | PK of combination therapy in resistant Gm -ves |
| 1/6/15 | PUW3 | ||
| 8/6/15 | PUW3 | Liana | PKPD of in vivo PKD model |
| 15/6/15 | PUW3 | All | PAGE review |
| 22/6/15 | PUW3 | Eva | PD neonatal infection modelling |
| 29/6/15 | PUW4 | Suzanne | PKPD of amisulpride |
| 6/7/15 | PUW3 | Ludo | PKPD in veterinary medicine |
| 13/7/15 | PUW3 | Roger Gunn | PK-PD modelling of CNS PET Molecular Imaging Studies |